SCHEMBL7654237

SCHEMBL7654237

CCOC(=O)C(C)(C)n1c(=O)c2cc(F)ccc2n(CCCCBr)c1=O

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PER2 O15055 8/20 0.38
ALDH1A1 P00352 3/20 0.38
HK1 P19367 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HKDC1 Q2TB90 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.37
CNR2 P34972 1/20 0.37
CRY1 Q16526 2/20 0.37
CRY2 Q49AN0 2/20 0.37
ACACB O00763 1/20 0.37
HTT P42858 1/20 0.37
TNF P01375 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
ELANE P08246 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7651232 0.90 RORA (0.41) ALDH1A1SMN1; SMN2CNR2HTTTNF
SCHEMBL7653483 0.88 ALDH1A1 (0.44) ALDH1A1CNR2HTTTNFKDM4E
SCHEMBL7651760 0.87 PTGDR2 (0.40) PER2PTGDR2CNR2CRY1CRY2
SCHEMBL7655134 0.85 TNF (0.51) ALDH1A1CNR2HTTTNFKDM4E
SCHEMBL7648481 0.85 MAPT (0.46) ALDH1A1LMNAELANE
SCHEMBL7649601 0.85 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2CNR2HTTTNF
SCHEMBL7651184 0.85 ALDH1A1 (0.50) ALDH1A1CNR2HTTTNFKDM4E
SCHEMBL7654850 0.85 ALDH1A1 (0.50) ALDH1A1CNR2HTTTNFKDM4E
SCHEMBL7653084 0.82 TNF (0.52) ALDH1A1CNR2HTTTNFKDM4E
SCHEMBL7654685 0.82 PSEN1 (0.42) ALDH1A1SMN1; SMN2HTTTNFKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407116-B1 2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLINE DERIVATIVES; ANTIALLERGENS, ANTIASTHMATICS, ANTIHISTAMINES, AND ANTIINFLAMMATORY AGENTS TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2002-06-18 US disclosed
EP-1026160-A1 NITROGENOUS FUSED-RING COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME, AND DRUGS Takeda Chemical Industries, Ltd. (JP) 2000-08-09 EP disclosed